Literature DB >> 17968639

Emotional reaction to fragile X premutation carrier tests among infertile women.

Lisa M Pastore1, Wendy L Morris, Logan B Karns.   

Abstract

Female fragile X premutation carriers are at approximately 10-fold increased risk of premature ovarian failure (follicle stimulating hormone >40 mIU/mL, amenorrhea, age <40). A milder degree of premature ovarian aging (diminished ovarian reserve, where follicle stimulating hormone levels are typically 10-20 mIU/mL) results in infertility. Approximately 10% of fertility clinic patients have this diagnosis. A cohort of 20 women diagnosed with diminished ovarian reserve provided a blood specimen (confidential results), and completed structured questionnaires that assessed emotional reactions to potentially being a premutation carrier (pretest questionnaire, n = 20) and the posttest known carrier status (3 month follow-up questionnaire, n = 18 non-carriers). Responses were measured using 9-point scales, and analyzed with Fisher exact and Wilcoxon exact tests. While most participants did not view fragile X premutations as a serious medical condition, perceptions of seriousness were positively correlated with anger and regret about not knowing sooner of the potential association of these premutations with infertility. Overall, when women (pretest) imagined themselves as carriers, their self-esteem and Health Orientation Scale responses were unchanged with the exception of feeling more afraid (p = 0.004). Despite strongly wishing for negative test results, they were glad to know there might be a medical explanation for their infertility.

Entities:  

Mesh:

Year:  2007        PMID: 17968639     DOI: 10.1007/s10897-007-9129-9

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  27 in total

1.  Evidence of early ovarian aging in fragile X premutation carriers.

Authors:  C K Welt; P C Smith; A E Taylor
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

2.  Familial transmission of the FMR1 CGG repeat.

Authors:  S L Nolin; F A Lewis; L L Ye; G E Houck; A E Glicksman; P Limprasert; S Y Li; N Zhong; A E Ashley; E Feingold; S L Sherman; W T Brown
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

3.  Longitudinal study of the carrier testing process for fragile X syndrome: perceptions and coping.

Authors:  A McConkie-Rosell; G A Spiridigliozzi; J A Sullivan; D V Dawson; A M Lachiewicz
Journal:  Am J Med Genet       Date:  2001-01-01

4.  Association of FMR1 repeat size with ovarian dysfunction.

Authors:  A K Sullivan; M Marcus; M P Epstein; E G Allen; A E Anido; J J Paquin; M Yadav-Shah; S L Sherman
Journal:  Hum Reprod       Date:  2004-12-17       Impact factor: 6.918

5.  Attitudes toward fragile X mutation carrier testing from women identified in a general population survey.

Authors:  Aimee Anido; Lisa M Carlson; Stephanie L Sherman
Journal:  J Genet Couns       Date:  2007-02-13       Impact factor: 2.537

Review 6.  The fragile-X premutation: a maturing perspective.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Am J Hum Genet       Date:  2004-03-29       Impact factor: 11.025

7.  Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age.

Authors:  R T Scott; M S Opsahl; M R Leonardi; G S Neall; E H Illions; D Navot
Journal:  Hum Reprod       Date:  1995-07       Impact factor: 6.918

8.  The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm.

Authors:  E Reyniers; L Vits; K De Boulle; B Van Roy; D Van Velzen; E de Graaff; A J Verkerk; H Z Jorens; J K Darby; B Oostra
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

9.  Apparent regression of the CGG repeat in FMR1 to an allele of normal size.

Authors:  L Vits; K De Boulle; E Reyniers; I Handig; J K Darby; B Oostra; P J Willems
Journal:  Hum Genet       Date:  1994-11       Impact factor: 4.132

10.  Fragile X syndrome: diagnostic and carrier testing.

Authors:  Stephanie Sherman; Beth A Pletcher; Deborah A Driscoll
Journal:  Genet Med       Date:  2005-10       Impact factor: 8.822

View more
  7 in total

Review 1.  Can we make assumptions about the psychosocial impact of living as a carrier, based on studies assessing the effects of carrier testing?

Authors:  Celine Lewis; Heather Skirton; Ray Jones
Journal:  J Genet Couns       Date:  2010-09-29       Impact factor: 2.537

2.  Longitudinal interviews of couples diagnosed with diminished ovarian reserve undergoing fragile X premutation testing.

Authors:  Lisa M Pastore; Logan B Karns; Karen Ventura; Myra L Clark; Richard H Steeves; Nancy Callanan
Journal:  J Genet Couns       Date:  2013-06-14       Impact factor: 2.537

3.  Molecular Characterization of FMR1 Gene by TP-PCR in Women of Reproductive Age and Women with Premature Ovarian Insufficiency.

Authors:  Deepika Delsa Dean; Sarita Agarwal; Deepa Kapoor; Kuldeep Singh; Chandra Vati
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

4.  Attitudes towards potentially carrying the FMR1 premutation: before vs after testing of non-carrier females with diminished ovarian reserve.

Authors:  Lisa M Pastore; Maria Antero; Karen Ventura; J Kim Penberthy; Semara A Thomas; Logan B Karns
Journal:  J Genet Couns       Date:  2014-05-03       Impact factor: 2.537

5.  Levels and associations among self-esteem, fertility distress, coping, and reaction to potentially being a genetic carrier in women with diminished ovarian reserve.

Authors:  Ceylan Cizmeli; Marci Lobel; Jason Franasiak; Lisa M Pastore
Journal:  Fertil Steril       Date:  2013-03-15       Impact factor: 7.329

6.  Men with an FMR1 premutation and their health education needs.

Authors:  Matthew B Walsh; Krista Charen; Lisa Shubeck; Allyn McConkie-Rosell; Nadia Ali; Cecelia Bellcross; Stephanie L Sherman
Journal:  J Genet Couns       Date:  2021-03-31       Impact factor: 2.717

Review 7.  The FMR1 gene, infertility, and reproductive decision-making: a review.

Authors:  Lisa M Pastore; Joshua Johnson
Journal:  Front Genet       Date:  2014-07-07       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.